# OnCo record nct06805305 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06805305/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06805305", "NCT06805305" ;
  schema:name "DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)"@en ;
  schema:description "A phase 2 trial of Temozolomide in glioma & glioblastoma, run by Diakonos Oncology Corporation, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06805305/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06805305> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-03-17" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/doc1021/> ;
  onco:companies <https://onco.cc/companies/diakonos-oncology/> .